Found: 15
Select item for more details and to access through your institution.
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 221, doi. 10.3350/cmh.2020.0239
- By:
- Publication type:
- Article
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 236, doi. 10.3350/cmh.2020.0204
- By:
- Publication type:
- Article
Current and future strategies for the treatment of chronic hepatitis C.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 246, doi. 10.3350/cmh.2020.0230
- By:
- Publication type:
- Article
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 257, doi. 10.3350/cmh.2021.0067
- By:
- Publication type:
- Article
A need for patient-centered care in managing patients with liver cirrhosis.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 270, doi. 10.3350/cmh.2021.0001
- By:
- Publication type:
- Article
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 273, doi. 10.3350/cmh.2021.0019
- By:
- Publication type:
- Article
Biopsy or cytology for diagnosing hepatic focal lesions?
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 278, doi. 10.3350/cmh.2021.0031
- By:
- Publication type:
- Article
Another oral antiviral treatment, but still far away from hepatitis B virus cure.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 281, doi. 10.3350/cmh.2021.0072
- By:
- Publication type:
- Article
Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 283, doi. 10.3350/cmh.2020.0227
- By:
- Publication type:
- Article
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 295, doi. 10.3350/cmh.2020.0216
- By:
- Publication type:
- Article
Direct comparison of biopsy techniques for hepatic malignancies.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 305, doi. 10.3350/cmh.2020.0301
- By:
- Publication type:
- Article
Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 313, doi. 10.3350/cmh.2020.0247
- By:
- Publication type:
- Article
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 329, doi. 10.3350/cmh.2020.0261
- By:
- Publication type:
- Article
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 346, doi. 10.3350/cmh.2020.0307
- By:
- Publication type:
- Article
Clinical and serological prognostic markers in primary biliary cholangitis.
- Published in:
- Clinical & Molecular Hepatology, 2021, v. 27, n. 2, p. 360, doi. 10.3350/cmh.2021.0088
- By:
- Publication type:
- Article